Longevity experts are mostly over Bryan Johnson's shtick and hope people consider the basics when it comes to taking care of ...
Collaboration to apply Lunit’s AI technologies across NCI’s broad spectrum of cancer studies, aiming to accelerate personalized cancer ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
THURSDAY, April 3, 2025 (HealthDay News) -- An experimental blood test might be able to help doctors predict whether someone ...
DMD treatment KER-065 showed a good safety profile in a Phase 1 clinical trial, with no serious side effects seen in healthy ...